Hee Jin Kim Selected Research

Presenilin-1

1/2021	A Case of Early-Onset Alzheimer's Disease Mimicking Schizophrenia in a Patient with Presenilin 1 Mutation (S170P).
4/2020	Pathological manifestation of the induced pluripotent stem cell-derived cortical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation (S170F).
1/2019	Dopa Responsive Parkinsonism in an Early Onset Alzheimer's Disease Patient with a Presenilin 1 Mutation (A434T).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hee Jin Kim Research Topics

Disease

62	Alzheimer Disease (Alzheimer's Disease) 05/2024 - 08/2007
59	Cognitive Dysfunction 01/2024 - 08/2007
23	Dementia (Dementias) 11/2023 - 08/2007
19	Atrophy 01/2024 - 01/2014
17	Parkinson Disease (Parkinson's Disease) 06/2020 - 09/2009
13	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2023 - 01/2012
12	Cerebral Small Vessel Diseases 11/2023 - 02/2015
12	Neoplasms (Cancer) 07/2023 - 02/2006
11	Tuberculosis (Tuberculoses) 07/2023 - 06/2004
11	Infections 03/2021 - 09/2003
10	Inflammation (Inflammations) 02/2024 - 12/2014
8	Hypertension (High Blood Pressure) 01/2024 - 02/2016
8	Cerebral Cortical Thinning 10/2020 - 01/2015
7	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 12/2020 - 02/2015
7	Stomach Neoplasms (Stomach Cancer) 11/2020 - 08/2008
6	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2022 - 04/2014
6	Atopic Dermatitis (Atopic Eczema) 10/2021 - 01/2016
6	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020 - 11/2013
6	Leprosy (Hansen's Disease) 02/2013 - 06/2004
5	Pain (Aches) 09/2023 - 04/2010
5	Disease Progression 01/2022 - 12/2012
4	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 07/2023 - 02/2016
4	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2023 - 01/2016
4	Dermatitis 07/2022 - 01/2016
4	Fever (Fevers) 02/2022 - 09/2003
4	Obesity 01/2021 - 01/2009
4	Latent Tuberculosis 01/2020 - 09/2015
4	Mixed Dementias 12/2018 - 01/2013
4	Ischemia 01/2018 - 10/2013
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023 - 01/2022
3	Sleep Initiation and Maintenance Disorders (Insomnia) 02/2022 - 01/2009
3	Hemorrhage 01/2022 - 08/2008
3	Neuralgia (Stump Neuralgia) 10/2021 - 05/2003
3	Primary Progressive Aphasia 01/2021 - 01/2016
3	Dyslipidemias (Dyslipidemia) 01/2021 - 02/2018
3	Epilepsy (Aura) 03/2020 - 03/2013
3	Amyloid Plaque 08/2018 - 01/2013
3	Stroke (Strokes) 06/2018 - 02/2016
3	Siderosis 01/2018 - 02/2015
3	Insulin Resistance 01/2017 - 01/2009
3	Adenomyosis 04/2011 - 09/2005
3	Leiomyoma (Uterine Fibroids) 02/2010 - 09/2005
2	Diarrhea 04/2024 - 01/2023
2	Atrophic Gastritis 02/2024 - 10/2015
2	Tobacco Use Disorder (Nicotine Dependence) 02/2024 - 12/2015
2	Headache (Headaches) 09/2023 - 09/2015
2	Substance-Related Disorders (Drug Abuse) 08/2023 - 09/2014
2	Medically Unexplained Symptoms 01/2023 - 05/2021
2	Neuroinflammatory Diseases 01/2023 - 03/2022
2	Metaplasia 11/2020 - 10/2015

Drug/Important Bio-Agent (IBA)

80	Amyloid (Amyloid Fibrils)IBA 01/2024 - 01/2013
23	Biomarkers (Surrogate Marker)IBA 01/2024 - 02/2009
19	Proteins (Proteins, Gene)FDA Link 03/2023 - 06/2004
18	Apolipoproteins E (ApoE)IBA 01/2023 - 11/2013
16	Amyloid beta-PeptidesIBA 01/2024 - 08/2007
11	5- aminocarbonyl- 10,11- dihydro- 5H- dibenzo(a,d)cyclohepten- 5,10- imine (ADCI)IBA 01/2023 - 05/2013
11	ApolipoproteinsIBA 01/2023 - 11/2013
10	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2018 - 01/2013
7	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2022 - 01/2018
6	Apolipoprotein E4IBA 01/2024 - 11/2013
6	Methylphenidate (Ritalin)FDA LinkGeneric 03/2022 - 01/2012
6	Indicators and Reagents (Reagents)IBA 06/2017 - 12/2005
5	CytokinesIBA 02/2024 - 09/2008
5	Retinaldehyde (Retinal)IBA 01/2024 - 01/2019
5	Therapeutic UsesIBA 07/2022 - 01/2012
4	Messenger RNA (mRNA)IBA 08/2023 - 01/2011
4	Rifampin (Rifampicin)FDA LinkGeneric 07/2023 - 03/2010
4	FluoroquinolonesIBA 07/2023 - 10/2012
4	Dopamine (Intropin)FDA LinkGeneric 01/2023 - 09/2009
4	Tuberculin (PPD)IBA 10/2019 - 12/2007
4	Levodopa (L Dopa)FDA LinkGeneric 01/2019 - 03/2011
4	AntigensIBA 08/2014 - 06/2004
3	Ethanol (Ethyl Alcohol)IBA 02/2024 - 03/2012
3	CholesterolIBA 11/2023 - 02/2016
3	Immunoglobulin E (IgE)IBA 07/2022 - 01/2016
3	THK5351IBA 03/2022 - 01/2018
3	Presenilin-1IBA 01/2021 - 01/2019
3	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 01/2020 - 01/2018
3	Capsaicin (Zostrix)FDA Link 01/2017 - 01/2016
3	Formaldehyde (Formol)FDA Link 01/2017 - 06/2011
3	AdiponectinIBA 01/2017 - 01/2009
3	Interferon-gamma (Interferon, gamma)IBA 09/2015 - 09/2008
3	Scopolamine (Hyoscine)FDA Link 01/2014 - 08/2007
3	EnzymesIBA 04/2010 - 06/2007
2	Bile Acids and Salts (Bile Acids)IBA 04/2024 - 01/2023
2	VaccinesIBA 09/2023 - 04/2012
2	Thyroid HormonesIBA 01/2023 - 01/2021
2	LipidsIBA 01/2023 - 02/2009
2	Dexamethasone (Maxidex)FDA LinkGeneric 08/2022 - 11/2010
2	Hypnotics and Sedatives (Sedatives)IBA 02/2022 - 01/2009
2	Donepezil (Aricept)FDA LinkGeneric 07/2021 - 07/2021
2	RNA (Ribonucleic Acid)IBA 03/2021 - 06/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2021
2	Interleukin-17 (Interleukin 17)IBA 01/2021 - 01/2019

Therapy/Procedure

12	Therapeutics 01/2023 - 09/2009
10	Deep Brain Stimulation 06/2020 - 09/2010
5	Uterine Artery Embolization 04/2011 - 09/2005
4	Injections 02/2022 - 07/2010
4	Activities of Daily Living (ADL) 01/2020 - 03/2011
2	Drug Therapy (Chemotherapy) 01/2021 - 07/2011